Skip to main content
TipRanks
Go Ultimate75% OFF

Vir Biotechnology (VIR) Revenue by Segment

1,580 Followers

Revenue by Segment

In Q2 2026, Vir Biotechnology reported revenue by segment of $238.94M (Collaboration) and $11.00K (Grant).

Provides insight into which business areas are driving sales, highlighting strengths and potential vulnerabilities in the company's revenue streams.

-$250.00M$0.00$250.00M$500.00M$750.00M$1.00B$1.25BMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Chart Insights

Revenue is clearly lumpy and milestone-driven—historical spikes came from a few large collaboration/contract recognitions while most recent quarters show a near-zero baseline as grant and contract receipts fade. The Astellas collaboration closed after quarter‑end and brings material near‑term cash and a pipeline of future milestones, but 40/60 development cost sharing and profit splits will blunt upside; going forward, timing of milestone recognition and clinical readouts, not recurring sales, will determine topline sustainability.

VIR Revenue by Segment

PeriodCollaborationGrantContract
Q2 2026Jun 30, 2026$238.94M$11.00K$0.00
Q1 2026Mar 31, 2026-$41.00K$12.00K$0.00
Q4 2025Dec 31, 2025$63.76M$310.00K$0.00
Q3 2025Sep 30, 2025-$65.00K$305.00K$0.00
Q2 2025Jun 30, 2025-$495.00K$183.00K$1.53M
Q1 2025Mar 31, 2025-$70.00K$1.24M$1.86M
Q4 2024Dec 31, 2024$10.41M$1.10M$865.00K
Q3 2024Sep 30, 2024-$1.10M$2.09M$1.39M
Q2 2024Jun 30, 2024$55.00K$2.13M$886.00K
Q1 2024Mar 31, 2024-$1.00M$5.20M$52.20M
Q4 2023Dec 31, 2023$8.90M$7.20M$700.00K
Q3 2023Sep 30, 2023$4.39M$6.74M$289.00K
Q2 2023Jun 30, 2023-$13.78M$16.52M$1.06M
Q1 2023Mar 31, 2023$46.60M$16.20M$100.00K
Q4 2022Dec 31, 2022$21.60M$27.60M$200.00K
Q3 2022Sep 30, 2022$309.10M$3.10M$40.00M
Q2 2022Jun 30, 2022-$54.94M$2.06M$12.25M
Q1 2022Mar 31, 2022$1.23B$2.52M$282.00K
Q4 2021Dec 31, 2021$809.46M$2.99M$293.00K
Q3 2021Sep 30, 2021$102.40M$903.00K$315.00K
Q2 2021Jun 30, 2021$5.33M$3.08M$168.65M
Q1 2021Mar 31, 2021$0.00$1.37M$605.00K
Q4 2020Dec 31, 2020$0.00$1.43M$301.00K
Q3 2020Sep 30, 2020$0.00$1.74M$188.00K
Q2 2020Jun 30, 2020$0.00$719.00K$43.52M
Q1 2020Mar 31, 2020$0.00$5.23M$487.00K
Q4 2019Dec 31, 2019$0.00$609.00K$371.00K
Q3 2019Sep 30, 2019$0.00$1.17M$237.00K
Q2 2019Jun 30, 2019$0.00$1.96M$86.00K
Q1 2019Mar 31, 2019$0.00$3.64M$17.00K

Related KPIs